Professional Psychiatric Services — research payments reported

By program year

3 rows

Year	Kind	Amount	Payments
2021	Research	$88,828	11
2020	Research	$49,427	13
2019	Research	$174,778	20

Breakdown

Who paid Research payments · program years 2019–2021

Allergan Inc. $292,509 39 payments
Shire North American Group Inc $15,524 4 payments
Otsuka Pharmaceutical Development & Commercialization, Inc. $5,000 1 payment

Studies the money was for Research payments · program years 2019–2021

Phase 4 (PMR Pediatric Gad) $84,513 4 payments
Phase 4 (PMR Pediatric Gad) $48,720 11 payments
A Double Blind, Placebo- and Active Controlled Evaluation of the Safety and Efficacy of Levomilnacipran Er in Adolescent Patients With Major Depressive Disorder $38,848 4 payments
A Randomized, Double-Blind, Placebo Controlled, Multicenter Study of Rapastinel As Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder $36,399 6 payments
A Multicenter, Double Blind, Placebo and Active-Controlled Parallel-Group Evaluation of the Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder $25,344 1 payment
A Double-Blind, Placebo-Controlled Study of Cariprazine As Adjunctive Therapy in Major Depressive Disorder $25,225 1 payment
An Open-Label Long-Term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder $21,620 1 payment
Safety and Tolerability Study of Shp465 in Children Aged 4 to 12 Years Diagnosed With Attention-Deficithyperactivity Disorder Adhd $6,866 1 payment
An Open Label, Long Term Safety Study of Rapastinel As An Adjunctive Therapy in Patients With Major Depressive Disorder MDD. $5,907 1 payment
A Multicenter, Randomized, Double-Blind, Placebo-And Active-Controlledtrial to Evaluate the Efficacy of Brexpiprazole Monotherapy for the Treatment in Adolescents 13-17 Years Old With Schizophrenia $5,000 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.